Search research articles
Contact Us
Filters
Showing results (21-30 of 75) with videos related to
Page
of 8
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2021
Patient-Reported Outcomes After Treatment Discontinuation: Commercial Clinical Trial Data From Four Cancer Types
Bellinda L King-Kallimanis, Nirosha Mahendraratnam Lederer, Janice Kim, et al.
The Lancet. Oncology
|
April 17, 2025
Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directions
Francesco Pignatti, Peter Mol, Chantal Quinten, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 10, 2024
Most Common Symptomatic Adverse Reactions of Cancer Treatments From US Drug Labels (2015-2021) to Inform Selection of Patient-Reported Outcomes
Erica G Horodniceanu, Tejaswi Datla, Meena N Murugappan, et al.
Journal of the National Cancer Institute
|
April 30, 2021
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective
Meena N Murugappan, Bellinda L King-Kallimanis, Gregory H Reaman, et al.
Journal of the National Cancer Institute
|
October 13, 2025
Multi-federal agency actions to integrate patient-reported outcomes into cancer research and care
Ashley Wilder Smith, Christine Dymek, Terri S Armstrong, et al.
The Lancet. Oncology
|
April 30, 2022
Time to deterioration of symptoms or function using patient-reported outcomes in cancer trials
Mallorie H Fiero, Jessica K Roydhouse, Vishal Bhatnagar, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 13, 2021
Does Knowledge of Treatment Assignment Affect Patient Report of Symptoms, Function, and Health Status? An Evaluation Using Multiple Myeloma Trials
Jessica K Roydhouse, Pallavi S Mishra-Kalyani, Vishal Bhatnagar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2025
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Treatment of Adult Patients With Hormone Receptor-Positive, Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2-Low or Human Epidermal Growth Factor Receptor 2-Ultralow Breast Cancer
Asma Dilawari, Hui Zhang, Mirat Shah, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
February 27, 2020
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease
Bellinda L King-Kallimanis, Tanya Wroblewski, Virginia Kwitkowski, et al.
The Oncologist
|
May 29, 2020
Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019
Vishal Bhatnagar, Stacie Hudgens, Elisabeth Piault-Louis, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 75) with videos related to
Sort By:
Page
of 8
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2021
Patient-Reported Outcomes After Treatment Discontinuation: Commercial Clinical Trial Data From Four Cancer Types
Bellinda L King-Kallimanis, Nirosha Mahendraratnam Lederer, Janice Kim, et al.
The Lancet. Oncology
|
April 17, 2025
Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directions
Francesco Pignatti, Peter Mol, Chantal Quinten, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 10, 2024
Most Common Symptomatic Adverse Reactions of Cancer Treatments From US Drug Labels (2015-2021) to Inform Selection of Patient-Reported Outcomes
Erica G Horodniceanu, Tejaswi Datla, Meena N Murugappan, et al.
Journal of the National Cancer Institute
|
April 30, 2021
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective
Meena N Murugappan, Bellinda L King-Kallimanis, Gregory H Reaman, et al.
Journal of the National Cancer Institute
|
October 13, 2025
Multi-federal agency actions to integrate patient-reported outcomes into cancer research and care
Ashley Wilder Smith, Christine Dymek, Terri S Armstrong, et al.
The Lancet. Oncology
|
April 30, 2022
Time to deterioration of symptoms or function using patient-reported outcomes in cancer trials
Mallorie H Fiero, Jessica K Roydhouse, Vishal Bhatnagar, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 13, 2021
Does Knowledge of Treatment Assignment Affect Patient Report of Symptoms, Function, and Health Status? An Evaluation Using Multiple Myeloma Trials
Jessica K Roydhouse, Pallavi S Mishra-Kalyani, Vishal Bhatnagar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2025
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Treatment of Adult Patients With Hormone Receptor-Positive, Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2-Low or Human Epidermal Growth Factor Receptor 2-Ultralow Breast Cancer
Asma Dilawari, Hui Zhang, Mirat Shah, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
February 27, 2020
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease
Bellinda L King-Kallimanis, Tanya Wroblewski, Virginia Kwitkowski, et al.
The Oncologist
|
May 29, 2020
Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019
Vishal Bhatnagar, Stacie Hudgens, Elisabeth Piault-Louis, et al.
Page
of 8